GlassScriptPhysician profile
Pierre G Daze
NPI 1538512751
$2,306.86
in general payments reported to CMS, 2019-2025
16 companies · $756 in 2025
The $756 reported for 2025 was more than what 75% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.93 · 2022: $177 · 2023: $884 · 2024: $468 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050 · Education: $57.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.80 |
| Education | $57.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $562.16 | 2022-2025 | Dupixent |
| Optinose US, INC. | $556.35 | 2022-2025 | |
| Genzyme Corporation | $242.77 | 2024-2025 | |
| Stryker Corporation | $191.05 | 2022-2023 | Xpress Ent Dilation System |
| Aerin Medical INC. | $159.80 | 2023-2025 | |
| Glaxosmithkline, LLC. | $158.14 | 2023-2025 | Nucala |
| Abbvie INC. | $138.11 | 2021-2022 | |
| Amgen INC. | $66.54 | 2025 | Tezspire |
| Ars Pharmaceuticals Operations, INC. | $49.65 | 2025 | Neffy |
| Vertex Pharmaceuticals Incorporated | $37.46 | 2025 | |
| Phadia US INC. | $34.79 | 2023-2025 | Immunocap |
| Pfizer INC. | $28.34 | 2023 | |
| Boston Scientific Corporation | $25.80 | 2025 | Wavewriter Alpha Prime 16 |
| Paratek Pharmaceuticals, INC. | $19.20 | 2025 | Xhance |
| Merck Sharp & Dohme LLC | $18.78 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17.92 | 2023 | Coblation |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pierre Daze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.